The DOI matches its Crossref record; 85 of the 87 references it cites were found in a registry or an index.
Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics
Open accessAbstract
The pathogenic mutation in Friedreich's ataxia (FRDA) is a homozygous guanine-adenine-adenine (GAA) trinucleotide repeat expansion on chromosome 9q13 that causes a transcriptional defect of the frataxin gene. Deficiency of frataxin, a small mitochondrial protein, is responsible for all clinical and morphological manifestations of FRDA. This autosomal recessive disease affects central and peripheral nervous systems, heart, skeleton, and endocrine pancreas. Long expansions lead to early onset, severe clinical illness, and death in young adult life. Patients with short expansions have a later onset and a more benign course. Some are not diagnosed during life. The neurological phenotype reflects lesions in dorsal root ganglia (DRG), sensory peripheral nerves, corticospinal tracts, and dentate nuclei (DN). Most patients succumb to cardiomyopathy, and many become diabetic during the course of their disease. This review seeks to reconcile the diverse clinical features with pathological and molecular data. In the pathogenesis of the lesion in DRG, dorsal spinal roots, and sensory peripheral nerves, developmental defects and atrophy occur in combination. The progressive lesion of the DN lacks a known developmental component. Destruction of the DN, optic atrophy, and degeneration of the corticospinal tracts are intrinsic central nervous system lesions. Fiber loss in dorsal columns and spinocerebellar tracts, and atrophy of the neurons in the dorsal nuclei of Clarke are secondary to the lesion in DRG. The role of frataxin deficiency in the pathogenesis of FRDA is still unclear because the protein has multiple functions in the normal state, including biogenesis of iron-sulfur clusters; iron chaperoning; iron storage; and control of iron-mediated oxidative tissue damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Decreased expression of frataxin also increases the Fenton reaction due to excess free iron (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“In addition, the hypoxia-induced suppression of Fe-S protein activity can be contrasted with the suppression of Fe-S protein activity found in Friedreich's ataxia, a hereditary neurogenerative disease that results from decreased production/function of the frataxin protein (17, 220).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [220]
In the citing paper
“Histological studies and MRI suggest that in human brains the highest iron accumulation occurs in the dentate nuclei of the cerebellum.166,167”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Clinical and Genetic Abnormalities in Patients with Friedreich's Ataxia
Dürr, A., Cossee, M., Agid, Y., Campuzano, V., Mignard, C., Penet, C., Mandel, J.-L., Brice, A., & Koenig, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351601 · Cited by 1,071
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Harding, A. E. (1981) · Brain · doi:10.1093/brain/104.3.589 · Cited by 929
Regulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Richardson, D. R., Lane, D. J. R., Becker, E. M., Huang, M. L.-H., Whitnall, M., Rahmanto, Y. S., Sheftel, A. D., & Ponka, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912925107 · Cited by 536
Filla, A., Michele, G. D., Cavalcanti, F., Pianese, L., Monticelli, A., Campanella, G., & Cocozza, S. (1996) · PubMed Central · Cited by 487
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Cossee, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1219 · Cited by 377
Research works printed but not linked: 2
- Mott, 1907, Case of Friedreich's disease, with autopsy and systematic microscopical examination of the nervous system, Arch Neurol Psychiat Lond, 3, 180
- Vassilopoulos, 1977, Étude radiologique de la colonne vertébrale cervicale dans certaines maladies dégéneratives neurologiques, J Radiol Électrol Méd Nucl, 58, 183
Cited by
Sorted by citations
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Redox regulation of mitochondrial function
Handy, D. E., & Loscalzo, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4123 · Cited by 588
Iron metabolism in the CNS: implications for neurodegenerative diseases
Rouault, T. A. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3453 · Cited by 496
Lane, D. J. R., Merlot, A. M., Huang, M. L.-H., Bae, D.-H., Jansson, P. J., Sahni, S., Kalinowski, D. S., & Richardson, D. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.021 · Cited by 399
Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease
Rouault, T. A. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009019 · Cited by 343
Clinical features of Friedreich's ataxia: classical and atypical phenotypes
Parkinson, M. H., Boesch, S., Nachbauer, W., Mariotti, C., & Giunti, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12317 · Cited by 292
Friedreich Ataxia: Neuropathology Revised
Koeppen, A. H., & Mazurkiewicz, J. E. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827e5762 · Cited by 273
Self-citationOxidative Stress and the Homeodynamics of Iron Metabolism
Bresgen, N., & Eckl, P. (2015) · Biomolecules · doi:10.3390/biom5020808 · Cited by 247
Friedreich’s ataxia: clinical features, pathogenesis and management
Cook, A., & Giunti, P. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx034 · Cited by 216
Maio, N., & Rouault, T. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.009 · Cited by 222
Sequencing the unsequenceable: Expanded CGG-repeat alleles of the fragile X genePreprint
Loomis, E. W., Eid, J. S., Peluso, P. S., Yin, J., Hickey, L., Rank, D. R., McCalmon, S. A., Hagerman, R. J., Tassone, F., & Hagerman, P. J. (2012) · Genome Research · doi:10.1101/gr.141705.112 · Cited by 203
Multi-Copper Oxidases and Human Iron Metabolism
Vashchenko, G., & MacGillivray, R. T. A. (2013) · Nutrients · doi:10.3390/nu5072289 · Cited by 223
Schneider, S. A., Hardy, J., & Bhatia, K. P. (2011) · Movement Disorders · doi:10.1002/mds.23971 · Cited by 180
Friedreich ataxia- pathogenesis and implications for therapies
Delatycki, M. B., & Bidichandani, S. I. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104606 · Cited by 168
Iron, zinc, and copper in retinal physiology and disease
Ugarte, M., Osborne, N. N., Brown, L. A., & Bishop, P. N. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.12.002 · Cited by 161
Huang, M., Chiang, S., Kalinowski, D. S., Bae, D.-H., Sahni, S., & Richardson, D. R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6392763 · Cited by 155
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
Ast, T., Meisel, J. D., Patra, S., Wang, H., Grange, R. M. H., Kim, S. H., Calvo, S. E., Orefice, L. L., Nagashima, F., Ichinose, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.045 · Cited by 160
Libri, V., Yandım, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., Chan, P. K., Mohammad, T., Mauri, M., Tam, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60382-2 · Cited by 156
Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 154
Outlining the Complex Pathway of Mammalian Fe-S Cluster Biogenesis
Maio, N., & Rouault, T. A. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.02.001 · Cited by 147
Friedreich Ataxia: current status and future prospects
Bürk, K. (2017) · Cerebellum & Ataxias · doi:10.1186/s40673-017-0062-x · Cited by 162
Martelli, A., & Puccio, H. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00130 · Cited by 148
Bota, D. A., & Davies, K. J. A. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.031 · Cited by 148
Szmulewicz, D. J., Roberts, L. J., McLean, C., MacDougall, H. G., Halmagyi, G. M., & Storey, E. (2016) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000215 · Cited by 139
Iron chelation in the treatment of neurodegenerative diseases
Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 135
ATXN2 trinucleotide repeat length correlates with risk of ALS
Sproviero, W., Shatunov, A., Stahl, D. R., Shoai, M., van Rheenen, W., Jones, A. R., Al‐Sarraj, S., Andersen, P. M., Bonini, N. M., Conforti, F. L., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.11.010 · Cited by 138
David, S., Jhelum, P., Ryan, F., Jeong, S. Y., & Kroner, A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0218 · Cited by 134
Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93885 · Cited by 128
Dorsal root ganglionopathy is responsible for the sensory impairment in CANVAS
Szmulewicz, D. J., McLean, C., Rodriguez, M. L., Chancellor, A. M., Mossman, S., Lamont, D. L., Roberts, L. J., Storey, E., & Waterston, J. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000352 · Cited by 127
The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
Koeppen, A. H., Ramirez, R. L., Becker, A. B., Bjork, S. T., Levi, S., Santambrogio, P., Parsons, P. J., Kruger, P. C., Yang, K. X., Feustel, P. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116396 · Cited by 126
Self-citationIron–sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia
Vaubel, R. A., & Isaya, G. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.003 · Cited by 123
Vitamin E is essential for Purkinje neuron integrity
Ulatowski, L., Parker, R., Warrier, G., Sultana, R., Butterfield, D. A., & Manor, D. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.001 · Cited by 122
Mitochondrial iron metabolism and neurodegenerative diseases
Cheng, R., Dhorajia, V. V., Kim, J., & Kim, Y. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.11.003 · Cited by 121
Cardiomyopathy of Friedreich Ataxia
Weidemann, F., Störk, S., Liu, D., Hu, K., Herrmann, S., Ertl, G., & Niemann, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12217 · Cited by 109
Mitochondrial iron-sulfur cluster dysfunction in neurodegenerative disease
Isaya, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00029 · Cited by 109
Emerging Opportunities To Manipulate Metal Trafficking for Therapeutic Benefit
Hunsaker, E. W., & Franz, K. J. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01029 · Cited by 109
Mammalian Fe–S cluster biogenesis and its implication in disease
Beilschmidt, L. K., & Puccio, H. M. (2014) · Biochimie · doi:10.1016/j.biochi.2014.01.009 · Cited by 113
Diffusion-MRI in neurodegenerative disorders
Goveas, J., O’Dwyer, L., Mascalchi, M., Cosottini, M., Diciotti, S., De Santis, S., Passamonti, L., Tessa, C., Toschi, N., & Giannelli, M. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.04.006 · Cited by 104
Cardiomyopathy in Friedreich Ataxia
Payne, R. M., & Wagner, G. R. (2012) · Journal of Child Neurology · doi:10.1177/0883073812448535 · Cited by 106
Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders
Paul, S., Bravo-Vázquez, L. A., Uribe, S. P., Reyes‐Pérez, P., & Sharma, A. K. (2020) · Cells · doi:10.3390/cells9071698 · Cited by 105
Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
Chandran, V., Gao, K., Swarup, V., Versano, R., Dong, H., Jordan, M. C., & Geschwind, D. H. (2017) · eLife · doi:10.7554/elife.30054 · Cited by 103
Central role and mechanisms of β‐cell dysfunction and death in friedreich ataxia–associated diabetes
Cnop, M., Igoillo‐Esteve, M., Rai, M., Corroller, A. B., Serroukh, Y. I. M., Depondt, C., Musuaya, A., Marhfour, I., Ladrière, L., Lopez, X. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23698 · Cited by 108
Self-citationExcision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia
Li, Y., Polak, U., Bhalla, A. D., Rozwadowska, N., Napierala, J. S., Lynch, D. R., Dent, S., & Напиерала, М. (2015) · Molecular Therapy · doi:10.1038/mt.2015.41 · Cited by 98
Iron–sulfur cluster biosynthesis and trafficking – impact on human disease conditions
Wachnowsky, C., Fidai, I., & Cowan, J. A. (2017) · Metallomics · doi:10.1039/c7mt00180k · Cited by 99
CANVAS an update: Clinical presentation, investigation and management
Szmulewicz, D. J., McLean, C., MacDougall, H. G., Roberts, L. J., Storey, E., & Waterston, J. A. (2014) · Journal of Vestibular Research · doi:10.3233/ves-140536 · Cited by 95
Farhan, S. M. K., Wang, J., Robinson, J. F., Lahiry, P., Siu, V. M., Prasad, C., Kronick, J. B., Ramsay, D. A., Rupar, C. A., & Hegele, R. A. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.46 · Cited by 76
Mitochondrial pathophysiology in Friedreich's ataxia
González‐Cabo, P., & Palau, F. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12303 · Cited by 99
Cnop, M., Mulder, H., & Igoillo‐Esteve, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12216 · Cited by 99
Gwathmey, K. G. (2015) · Muscle & Nerve · doi:10.1002/mus.24943 · Cited by 93
Cotticelli, M. G., Crabbe, A. M., Wilson, R. B., & Shchepinov, M. S. (2013) · Redox Biology · doi:10.1016/j.redox.2013.06.004 · Cited by 91
Friedreich's Ataxia Causes Redistribution of Iron, Copper, and Zinc in the Dentate Nucleus
Koeppen, A. H., Ramirez, R. L., Yu, D., Collins, S. E., Qian, J., Parsons, P. J., Yang, K. X., Chen, Z., Mazurkiewicz, J. E., & Feustel, P. J. (2012) · The Cerebellum · doi:10.1007/s12311-012-0383-5 · Cited by 87
Self-citationAnimal and cellular models of Friedreich ataxia
Perdomini, M., Hick, A., Puccio, H. M., & Pook, M. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12219 · Cited by 92
Kadirvelu, B., Gavriel, C., Nageshwaran, S., Chan, J. P. K., Nethisinghe, S., Athanasopoulos, S., Ricotti, V., Voït, T., Giunti, P., Festenstein, R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-022-02159-6 · Cited by 84
Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation
Koeppen, A. H., Ramirez, R. L., Becker, A. B., & Mazurkiewicz, J. E. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0288-5 · Cited by 82
Self-citationTriplex technology in studies of DNA damage, DNA repair, and mutagenesis
Mukherjee, A., & Vásquez, K. M. (2011) · Biochimie · doi:10.1016/j.biochi.2011.04.001 · Cited by 84
Chen, K., Lin, G., Haelterman, N. A. T., Ho, T. S., Li, T., Li, Z., Duraine, L., Graham, B. H., Jaiswal, M., Yamamoto, S., et al. (2016) · eLife · doi:10.7554/elife.16043 · Cited by 81
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
Petrillo, S., D’Amico, J., Rosa, P. L., Bertini, E., & Piemonte, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205211 · Cited by 79
Friedreich Ataxia: Clinical Features and New Developments
Keita, M., McIntyre, K., Rodden, L. N., Schadt, K. A., & Lynch, D. R. (2022) · Neurodegenerative Disease Management · doi:10.2217/nmt-2022-0011 · Cited by 87
Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia
Igoillo‐Esteve, M., Oliveira, A. F., Cosentino, C., Fantuzzi, F., Demarez, C., Toivonen, S., Hu, A., Chintawar, S., Lopes, M., Pachera, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.134221 · Cited by 78
Chan, P. K., Torres, R., Yandım, C., Law, P. P., Khadayate, S. P., Mauri, M., Groşan, C., Chapman‐Rothe, N., Giunti, P., Pook, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt115 · Cited by 84
Shahrani, M. M. A., Heales, S., Hargreaves, I. P., & Orford, M. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6110100 · Cited by 79
Teive, H. A. G., & Ashizawa, T. (2015) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000227 · Cited by 77
High Levels of Frataxin Overexpression Lead to Mitochondrial and Cardiac Toxicity in Mouse Models
Belbellaa, B., Reutenauer, L., Messaddeq, N., Monassier, L., & Puccio, H. M. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.08.018 · Cited by 78
Martelli, A., Напиерала, М., & Puccio, H. M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008706 · Cited by 80
Natural History of Friedreich Ataxia
Rummey, C., Corben, L. A., Delatycki, M. B., Wilmot, G. R., Subramony, S. H., Corti, M., Bushara, K. O., Duquette, A., Gomez, C. M., Hoyle, J. C., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200913 · Cited by 74
DNA Mismatch Repair Complex MutSβ Promotes GAA·TTC Repeat Expansion in Human Cells
Halabi, A., Ditch, S., Wang, J., & Grabczyk, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356758 · Cited by 74
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Stacpoole, P. W., & McCall, C. E. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.007 · Cited by 70
Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia
Igoillo‐Esteve, M., Gurgul-Convey, E., Hu, A., Santos, L. R. B., Abdulkarim, B., Chintawar, S., Marselli, L., Marchetti, P., Jonas, J., Eizirik, D. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu745 · Cited by 67
MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis
Hsu, Y.-H. R., Yogasundaram, H., Parajuli, N., Valtuille, L., Sergi, C. M., & Oudit, G. Y. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9524-5 · Cited by 68
Multiple system atrophy of the cerebellar type: Clinical state of the art
Lin, D. J., Hermann, K. L., & Schmahmann, J. D. (2014) · Movement Disorders · doi:10.1002/mds.25847 · Cited by 67
Gerhardt, J., Bhalla, A. D., Napierala, J. S., Puckett, J. W., Dervan, P. B., Rosenwaks, Z., & Напиерала, М. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.075 · Cited by 66
Cerebellar pathology in Friedreich's ataxia: Atrophied dentate nuclei with normal iron content
Solbach, K., Kraff, O., Minnerop, M., Beck, A., Schöls, L. J., Gizewski, E. R., Ladd, M. E., & Timmann, D. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.08.018 · Cited by 66
Oxidative stress and altered lipid metabolism in Friedreich ataxia
Tamarit, J., Òbis, È., & Ros, J. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.007 · Cited by 66
Zhao, H., Li, H., Hao, S., Chen, J., Wu, J., Song, C., Zhang, M., Qiao, T., & Li, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-10320-2 · Cited by 67
Molecular Alterations in a Mouse Cardiac Model of Friedreich Ataxia
Anzovino, A., Chiang, S., Brown, B. E., Hawkins, C. L., Richardson, D. R., & Huang, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.08.021 · Cited by 64
Purkinje cell injury, structural plasticity and fusion in patients with Friedreich’s ataxia
Kemp, K. C., Cook, A. J., Redondo, J., Kurian, K. M., Scolding, N. J., & Wilkins, A. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0326-3 · Cited by 62
Dentate Update: Imaging Features of Entities That Affect the Dentate Nucleus
Bond, K. M., Brinjikji, W., Eckel, L. J., Kallmes, D. F., McDonald, R. J., & Carr, C. M. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5138 · Cited by 64
Iron chelation and multiple sclerosis
Weigel, K. J., Lynch, S. G., & LeVine, S. M. (2014) · ASN NEURO · doi:10.1042/an20130037 · Cited by 63
A novel GAA repeat expansion-based mouse model of Friedreich ataxia
Virmouni, S. A., Ezzatizadeh, V., Sandi, C., Sandi, M., Al‐Mahdawi, S., Chutake, Y. K., & Pook, M. A. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018952 · Cited by 62
Rodríguez‐Pascau, L., Britti, E., Calap-Quintana, P., Dong, Y., Vergara, C., Delaspre, F., Medina‐Carbonero, M., Tamarit, J., Pallardó, F. V., González‐Cabo, P., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105162 · Cited by 62
Molecular and Functional Alterations in a Mouse Cardiac Model of Friedreich Ataxia
Huang, M., Sivagurunathan, S., Ting, S., Jansson, P. J., Austin, C., Kelly, M., Semsarian, C., Zhang, D., & Richardson, D. R. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.032 · Cited by 62
Mitoferrin modulates iron toxicity in a Drosophila model of Friedreich׳s ataxia
Navarro, J. A., Botella, J., Metzendorf, C., Lind, M., & Schneuwly, S. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.014 · Cited by 60
Tomassini, B., Arcuri, G., Fortuni, S., Sandi, C., Ezzatizadeh, V., Casali, C., Condò, I., Malisan, F., Al‐Mahdawi, S., Pook, M. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds110 · Cited by 60
Cerebral abnormalities in Friedreich ataxia: A review
Selvadurai, L. P., Harding, I. H., Corben, L. A., & Georgiou‐Karistianis, N. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.006 · Cited by 60
Ezzatizadeh, V., Pinto, R. M., Sandi, C., Sandi, M., Al‐Mahdawi, S., Riele, H. T., & Pook, M. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.002 · Cited by 62
Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
Chen, K., Ho, T. S., Lin, G., Tan, K. L., Rasband, M. N., & Bellen, H. J. (2016) · eLife · doi:10.7554/elife.20732 · Cited by 61
METTL17 is an Fe-S cluster checkpoint for mitochondrial translation
Ast, T., Itoh, Y., Sadre, S., McCoy, J. G., Namkoong, G., Wengrod, J. C., Chicherin, I., Joshi, P. R., Kamenski, P., Suess, D. L. M., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.12.016 · Cited by 58
Open-label pilot study of interferon gamma-1b in Friedreich ataxia
Seyer, L. A., Greeley, N. R., Foerster, D. L., Strawser, C. J., Gelbard, S., Dong, Y., Schadt, K. A., Cotticelli, M. G., Brocht, A. F. D., Farmer, J. M., et al. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12337 · Cited by 58
Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia
Chiang, S., Kovačević, Ž., Sahni, S., Lane, D. J. R., Merlot, A. M., Kalinowski, D. S., Huang, M. L. H., & Richardson, D. R. (2016) · Clinical Science · doi:10.1042/cs20160072 · Cited by 58
Cerebello-cerebral connectivity deficits in Friedreich ataxia
Zalesky, A., Akhlaghi, H., Corben, L. A., Bradshaw, J. L., Delatycki, M. B., Storey, E., Georgiou‐Karistianis, N., & Egan, G. F. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0547-1 · Cited by 58
Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis
Hadzhieva, M., Kirches, E., Wilisch-Neumann, A., Pachow, D., Wallesch, M., Schoenfeld, P., Paege, I., Vielhaber, S., Petri, S., Keilhoff, G., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.021 · Cited by 56
Fixing frataxin: ‘ironing out’ the metabolic defect in F riedreich's ataxia
Anzovino, A., Lane, D. J. R., Huang, M., & Richardson, D. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12470 · Cited by 56
Relation of Cytosolic Iron Excess to Cardiomyopathy of Friedreich's Ataxia
Ramirez, R. L., Qian, J., Santambrogio, P., Levi, S., & Koeppen, A. H. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.018 · Cited by 54
Self-citationCárdenas‐Rodríguez, N., Coballase-Urrutía, E., Perez‐Cruz, C., Montesinos-Correa, H., Rivera-Espinosa, L., Sampieri, A. I., & Carmona‐Aparicio, L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/759293 · Cited by 53
Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia
Xia, H., Cao, Y., Dai, X., Marelja, Z., Zhou, D., Mo, R., Al‐Mahdawi, S., Pook, M. A., Leimkühler, S., Rouault, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047847 · Cited by 54
de Rezende, T. J. R., da Silva, C. B., Yasuda, C. L., de Campos, B. M., D’Abreu, A., Cendes, F., Lopes‐Cendes, Í., & França, M. C. (2015) · Movement Disorders · doi:10.1002/mds.26436 · Cited by 52
Probing the neuroanatomy of the cerebellum using tractography
Habas, C., & Manto, M. U. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63956-1.00014-x · Cited by 52
Chiang, S., Kalinowski, D. S., Jansson, P. J., Richardson, D. R., & Huang, M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.002 · Cited by 48
Metadata
- Authors
- Koeppen, A. H.
- Affiliations
- Albany Stratton VA Medical Center Albany (US)
- Corresponding author
- Koeppen, Arnulf H.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 303
- Issue
- 1-2
- Pages
- 1-12
- ISSN
- 0022-510X (ISSN-L)
- PMC
- PMC3062632
- OpenAlex
- W1985093325
- Cited by
- 447
- References
- 87
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 36 · 2023: 34 · 2022: 18 · 2021: 22 · 2020: 25 · 2019: 27 · 2018: 21 · 2017: 27 · 2016: 30 · 2015: 30 · 2014: 38 · 2013: 52 · 2012: 28
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Friedreich's Ataxia Research Alliance
- National Ataxia Foundation
- National Institutes of Health
- Neurochemical Research, Inc.
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Friedreich's ataxia, GAA trinucleotide repeat expansion, frataxin deficiency, frataxin gene, iron chaperone, dorsal root ganglia, sensory neuropathy, dentate nucleus, corticospinal tract degeneration, cardiomyopathy, diabetes mellitus, autosomal recessive disorder, pathogenesis, clinical phenotype
- MeSH terms
- Frataxin, Adolescent, Adult, Aged, Animals, Child, Child, Preschool, Disease Models, Animal, Female, Friedreich Ataxia, Humans, Infant, Male, Middle Aged, Spinal Cord, Age of Onset, Iron-Binding Proteins, History, 19th Century, History, 20th Century, History, 21st Century, Mice, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review